Search

Your search keyword '"Hoover, M."' showing total 458 results
Start Over Author "Hoover, M."
458 results on '"Hoover, M."'

180. SUPERSIZED INDOOR COMPOSTING FACILITY.

Author

Alix, C., Hoover, M., Sullivan, M., Gundlach, J., and Soroushian, F.

Subjects
*WASTE recycling, *COMPOSTING, *FACILITIES, *ORGANIC wastes, *SOIL amendments, *SOLIDS, *LOCAL government
Abstract

The article reflects on the supersized indoor composting facility in Southern California in relation with the biosolids management. Cities and counties in this region have managed biosolids since the promulgation of federal regulations. However, the dynamic has changed radically in a short time due to the inconvenience of the general public. Some of local agencies have adopted strategies for dealing with the new dynamic. These include collaborating on solutions when possible and developing refined products that can be reused within the region to improve soil health.

Published
2006

181. Practical process hydraulics considerations.

Author

Schneider, D. F. and Hoover, M. C.

Subjects
*PETROLEUM chemicals industry, *HYDROCARBONS, *FLUID dynamics, *MANUFACTURING processes
Abstract

Deals with fluid flow problems in the hydrocarbon processing industry. Two-phase fluids; Hot vapor bypass; Unexpected piping lengths that impact process hydraulics.

Published
1999

183. RADIATION PROTECTION FOR URANIUM MINERS.

Author

Hoover, M. D., Howie, W. L., and Miller, A. L.

Subjects
MINE safety, URANIUM mining
Abstract

An abstract of the article "Radiation Protection for Uranium Miners," by M. D. Hoover, W. L. Howie and A. L. Miller is presented.

Published
2008

198. Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue.

Author

Cohn, S L, Moss, T J, Hoover, M, Katzenstein, H M, Haut, P R, Morgan, E R, Green, A A, and Kletzel, M

Subjects
*NEUROBLASTOMA, *DRUG therapy, *STEM cells
Abstract

A single institutional pilot study was conducted in which 12 poor-risk neuroblastoma (NB) patients were uniformly treated with multi-agent induction chemotherapy followed by myeloablative consolidation chemotherapy and unpurged peripheral blood stem cell (PBSC) rescue. In addition to using standard criteria for evaluating response to induction chemotherapy, tumor cell contamination of the peripheral blood and/or bone marrow was analyzed in seven patients by immunocytology using a panel of five anti-NB monoclonal antibodies. Seven patients had morphologic evidence of bone marrow disease at the time of diagnosis, and two additional patients had tumor cells detected in bone marrow samples by immunocytology prior to the second cycle of chemotherapy. After three cycles of chemotherapy, two of the 12 patients continued to have evidence of bone marrow disease. Samples from 29 PBSC harvests collected from nine patients were also analyzed for the presence of contaminating tumor cells by immunocytology. In each case, the stem cells were found to be free of tumor. Eleven of the 12 patients underwent myeloablative therapy and PBSC rescue; five patients remain alive without disease progression, 28+ to 53+ months from diagnosis, and six patients have developed recurrent disease. We conclude that PBSCs can be successfully harvested from children with NB, and used for hematopoietic reconstitution following myeloablative chemotherapy. However, more effective therapy for poor-risk NB patients is still urgently needed. [ABSTRACT FROM AUTHOR]

Published
1997
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results